Dermatologicals in the Netherlands

 Published On: Sep, 2016 |    No of Pages: 32 |  Published By: Euromonitor | Format: PDF
Dermatologicals increased by 3% in current value terms in 2016, to reach 67 million. The ageing population drove growth in retail sales of dermatologicals, as ageing skin loses collagen, leading to skin problems. Besides general dermatologicals, topical allergy treatments are also often used by the elderly. Furthermore, the growing number of people with skin-related issues also promoted growth in dermatologicals in 2016. More than 1.2 million Dutch people have skin-related problems, 20% have ec...

Dermatologicals in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN THE NETHERLANDS

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
Bayer Consumer Care BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 1 Bayer Consumer Care BV: Key Facts
Summary 2 Bayer Consumer Care BV: Operational Indicators
Competitive Positioning
Summary 3 Bayer Consumer Care BV: Competitive Position 2016
Omega Pharma Nederland BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 4 Omega Pharma Nederland BV: Key Facts
Summary 5 Omega Pharma Operational Indicators
Competitive Positioning
Summary 6 Omega Pharma Nederland BV: Competitive Position 2016
Pfizer BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 7 Pfizer BV: Key Facts
Summary 8 Pfizer BV: Operational Indicators
Competitive Positioning
Summary 9 Pfizer BV: Competitive Position 2016
Remark Pharma BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 10 Remark Pharma BV: Key Facts
Summary 11 Remark Pharma BV: Key Facts
Competitive Positioning
Summary 12 Remark Pharma BV: Key Facts
Vemedia BV in Consumer Health (netherlands)
Strategic Direction
Key Facts
Summary 13 Vemedia BV: Key Facts
Summary 14 Vemedia BV: Operational Indicators
Competitive Positioning
Summary 15 Vemedia BV: Competitive Position 2016
Executive Summary
Consumer Health Records A Positive Value Performance in 2016
the Weather Conditions Fuel Sales in Consumer Health
Companies Join Forces To Strengthen Their Positions in Consumer Health
Retail Environment Is Changing Due To Changing Consumer Patterns
Consumer Health Is Expected To Experience Moderate Value Growth Over the Forecast Period
Key Trends and Developments
Consumers Are Adopting Healthy Lifestyles
the Ageing Population in the Netherlands
A Shift in Focus Away From Treatment Towards Prevention
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 16 OTC: Switches 2014-2016
Sources
Summary 17 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.